Dott. Andrea Pasta

Formazione

• Università degli Studi di Genova, Laurea in Medicina e Chirurgia
• Università degli Studi di Genova, Specializzazione in Malattie dell'Apparato Digerente
• Università degli Studi di Genova, Dottorato di Ricerca in Malattie dell'Apparato Digerente e del Fegato (in corso)

Competenze linguistiche

• Inglese
• Italiano

Premi e riconoscimenti

Pubblicazioni

• Pasta A, Formisano E, Calabrese F, Apollonio M, Demarzo MG, Marabotto E, Furnari M, Giannini EG, Pisciotta L, Bodini G. The use of the Crohn's disease exclusion diet (CDED) in adults with Crohn's disease: A randomized controlled trial. Eur J Clin Invest. 2025 Jan 24:e14389.
• Pasta A, Facciorusso A, Plaz Torres MC, Giannini EG, Sacco R. Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis. Eur J Clin Invest. 2025 Feb 12:e70000
• Savarino, V., Visaggi, P., Marabotto, E., Bertin, L., Pasta, A., Calabrese, F., Zentilin, P., Ghisa, M., Ribolsi, M., Mari, A., Tolone, S., de Bortoli, N., & Savarino, E. V. (2025). Topical Protection of Esophageal Mucosa as a New Treatment of GERD. Journal of clinical gastroenterology, 10.1097/MCG.0000000000002128. Advance online publication.
• Giannini EG, Pasta A, Plaz Torres MC, et al. Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma. Liver Int. 2025;45(2):e16185. doi:10.1111/liv.16185
• Ferrari, D., Siboni, S., Sozzi, M., Visaggi, P., Kristo, I., Tolone, S., Marabotto, E., Bernardi, D., Schoppmann, S. F., Rogers, B. D., Hobson, A., Haworth, J., Lee, Y. Y., Louie, B. E., Masuda, T., Ivy, M. L., Milito, P., Centorrino, E., Theodorou, D., Triantafyllou, T., … De Bortoli, N. (2025). The Milan Score Predicts Objective Gastroesophageal Reflux Disease in Patients With Type 2 Esophagogastric Junction. Neurogastroenterology and motility, e14987. Advance online publication. https://doi.org/10.1111/nmo.14987
• Giannini EG, Pasta A, Calabrese F, et al. Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis. Liver Int. 2025;45(1):e16222. doi:10.1111/liv.16222
• Mocci, G., Tursi, A., Scaldaferri, F., Napolitano, D., Pugliese, D., Capobianco, I., Bartocci, B., Blasi, V., Savarino, E. V., Maniero, D., Redavid, C., Lorenzon, G., Cuomo, A., Donnarumma, L., Gravina, A. G., Pellegrino, R., Bodini, G., Pasta, A., Marzo, M., Serio, M., … Papa, A. (2024). Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study. Journal of clinical medicine, 13(23), 7192. https://doi.org/10.3390/jcm13237192
• Pasta A, Calabrese F, Marabotto E, et al. Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn's Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies. Diseases. 2024;12(11):295. Published 2024 Nov 19. doi:10.3390/diseases12110295
• Marabotto E, Calabrese F, Pasta A, et al. Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults. Expert Opin Pharmacother. 2024;25(17):2319-2325. doi:10.1080/14656566.2024.2427335
• Pasta A, Calabrese F, Savarino EV, Giannini EG, Marabotto E. Role of prokinetics in ineffective esophageal motility: A call for broader consideration and future innovations. Neurogastroenterol Motil. 2025;37(2):e14961. doi:10.1111/nmo.14961
• Calabrese F, Pasta A, Savarino EV, Savarino V, Giannini EG, Marabotto E. Expanding Insights on Ambulatory Reflux Monitoring: Future Directions and Clinical Integration. Am J Gastroenterol. Published online October 18, 2024. doi:10.14309/ajg.0000000000003080
• Marabotto E, Pasta A, Calabrese F, et al. The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions. Visc Med. 2024;40(5):242-249. doi:10.1159/000536583
• Visaggi P, Bertin L, Pasta A, et al. Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024. Expert Opin Pharmacother. 2024;25(15):2077-2088. doi:10.1080/14656566.2024.2416585
• Kayali S, Calabrese F, Pasta A, et al. Effect of hiatal hernia and esophagogastric junction morphology on esophageal motility: Evidence from high-resolution manometry studies. Neurogastroenterol Motil. 2024;36(12):e14929. doi:10.1111/nmo.14929
• Gravina, A. G., Pellegrino, R., Palladino, G., Imperio, G., Calabrese, F., Pasta, A., Giannini, E. G., Federico, A., & Bodini, G. (2024). Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand. Biomolecules, 14(9), 1164. https://doi.org/10.3390/biom14091164
• Sorge, A., Aldinio, G., Marinoni, B., Visaggi, P., Penagini, R., Maniero, D., Ghisa, M., Marabotto, E., de Bortoli, N., Pasta, A., Dipace, V., Calabrese, F., Vecchi, M., Savarino, E. V., & Coletta, M. (2025). Distribution of esophageal inflammation in patients with eosinophilic esophagitis and its impact on diagnosis and outcome. Digestive and liver disease, 57(1), 260–265. https://doi.org/10.1016/j.dld.2024.08.049
• Visaggi, P., Ghisa, M., Vespa, E., Barchi, A., Mari, A., Pasta, A., Marabotto, E., de Bortoli, N., & Savarino, E. V. (2024). Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes. ImmunoTargets and therapy, 13, 367–383. https://doi.org/10.2147/ITT.S276869
• Pasta A, Facchini C, Calabrese F, et al. Esophageal motor disorders across ages: A retrospective multicentric analysis. J Am Geriatr Soc. 2024;72(9):2782-2791. doi:10.1111/jgs.19068
• Pasta A, Calabrese F, Bodini G. Response to Letter to Editor on "Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission". J Gastrointestin Liver Dis. 2024;33(2):281. Published 2024 Jun 29. doi:10.15403/jgld-5660
• Pasta, A., Calabrese, F., Ghezzi, A., Savarino, E. V., Savarino, V., Zentilin, P., Furnari, M., Bodini, G., Giannini, E. G., & Marabotto, E. (2024). Diagnostic delay in achalasia. Digestive and liver disease, 56(11), 1839–1844. https://doi.org/10.1016/j.dld.2024.05.001
• Pasta A, Calabrese F, Jaffe A, et al. Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis. Liver Cancer. 2023;13(3):227-237. Published 2023 Oct 14. doi:10.1159/000533991
• Calabrese F, Pasta A, Bodini G, et al. Editorial: Diagnosis of GERD in patients with extra-oesophageal symptoms-still a long way to go… Authors' reply'. Aliment Pharmacol Ther. 2024;59(9):1150-1151. doi:10.1111/apt.17960
• Bertin, L., Barberio, B., Gubbiotti, A., Bertani, L., Costa, F., Ceccarelli, L., Visaggi, P., Bodini, G., Pasta, A., Sablich, R., Urbano, M. T., Ferronato, A., Buda, A., De Bona, M., Del Corso, G., Massano, A., Angriman, I., Scarpa, M., Zingone, F., & Savarino, E. V. (2024). Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease. Journal of clinical medicine, 13(6), 1539. https://doi.org/10.3390/jcm13061539
• Pasta, A., Pieri, G., Plaz Torres, M. C., Trevisani, F., Giannini, E. G., & Italian Liver Cancer (ITA.LI.CA) Group (2024). Hepatocellular carcinoma in patients with autoimmune hepatitis. Journal of hepatology, 81(3), e131–e132. https://doi.org/10.1016/j.jhep.2024.03.025
• Pasta, A., Pelizzaro, F., Marabotto, E., Calabrese, F., Formisano, E., Djahandideh Sheijani, S., Brandimarte, G., Manes, G., Gravina, A. G., & Savarino, E. V. (2024). Patient journey in gastroesophageal reflux disease: real-world perspectives from Italian gastroenterologists, primary care physicians, and ENT specialists. Therapeutic advances in gastroenterology, 17, 17562848241239590. https://doi.org/10.1177/17562848241239590
• Calabrese, F., Pasta, A., Bodini, G., Furnari, M., Zentilin, P., Giannini, E. G., Maniero, D., Della Casa, D., Cataudella, G., Frazzoni, M., Penagini, R., Elena, A., de Bortoli, N., Visaggi, P., Savarino, V., Savarino, E., & Marabotto, E. (2024). Applying Lyon consensus criteria in the work-up of patients with extra-oesophageal symptoms - A multicentre retrospective study. Alimentary pharmacology & therapeutics, 59(9), 1134–1143. https://doi.org/10.1111/apt.17934
• Giannini EG, Pasta A, Pieri G, et al. Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma. Liver Int. 2024;44(7):1588-1599. doi:10.1111/liv.15855
• Pasta, A., Formisano, E., Calabrese, F., Plaz Torres, M. C., Bodini, G., Marabotto, E., Pisciotta, L., Giannini, E. G., & Furnari, M. (2024). Food Intolerances, Food Allergies and IBS: Lights and Shadows. Nutrients, 16(2), 265. https://doi.org/10.3390/nu16020265
• Tursi, A., Mocci, G., Scaldaferri, F., Napolitano, D., Maresca, R., Pugliese, D., Semprucci, G., Savarino, E., Cuomo, A., Donnarumma, L., Bodini, G., Pasta, A., Maconi, G., Cataletti, G., Pranzo, G., Rodinò, S., Sebkova, L., Costa, F., Ferronato, A., Gaiani, F., … Papa, A. (2024). Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study. Expert opinion on biological therapy, 24(1-2), 101–109. https://doi.org/10.1080/14712598.2024.2309300
• Pasta A, Calabrese F, Djahandideh Sheijani S, et al. Expression of epidermal growth factor receptor (EGFR) in systemic sclerosis patients (SSc) and gastro-oesophageal reflux disease (GORD). Immunol Lett. 2024;265:31-36. doi:10.1016/j.imlet.2023.106834
• Bodini G, Ghezzi A, Pasta A, et al. Reduction of Fecal Calprotectin Levels Induced by a Short Course of Escherichia Coli Nissle is Associated with a Lower Likelihood of Disease Flares in Patients with Ulcerative Colitis in Clinical Remission. J Gastrointestin Liver Dis. 2023;32(4):438-443. Published 2023 Dec 22. doi:10.15403/jgld-4932
• Pasta, A., Calabrese, F., Plaz Torres, M. C., Bodini, G., Furnari, M., Savarino, E. V., Savarino, V., Giannini, E. G., & Marabotto, E. (2023). Albumin-bilirubin score in non-malignant liver diseases should be properly validated. World journal of gastroenterology, 29(46), 6089–6091. https://doi.org/10.3748/wjg.v29.i46.6089
• Labanca S, Pasta A, Cariati S, et al. Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?. Liver Transpl. 2024;30(5):E28-E29. doi:10.1097/LVT.0000000000000315
• Marabotto E, Pasta A, Calabrese F, et al. Is global score better than a single histological parameter for assessing microscopic esophagitis?. Neurogastroenterol Motil. 2024;36(1):e14685. doi:10.1111/nmo.14685
• Pelizzaro F, Trevisani F, Simeon V, et al. Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection. Liver Int. 2023;43(12):2762-2775. doi:10.1111/liv.15719
• Djahandideh Sheijani S, Calabrese F, Pasta A, et al. Clopidogrel-Induced Eosinophilic Colitis. ACG Case Rep J. 2023;10(8):e01118. Published 2023 Aug 3. doi:10.14309/crj.0000000000001118
• Marten Canavesio Y, Pasta A, Calabrese F, et al. Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study. Rheumatol Int. 2024;44(12):2905-2910. doi:10.1007/s00296-023-05399-y
• Pasta A, Calabrese F, Labanca S, et al. Safety and efficacy of venous thromboembolism prophylaxis in patients with cirrhosis: A systematic review and meta-analysis. Liver Int. 2023;43(7):1399-1406. doi:10.1111/liv.15609
• Pasta A, Calabrese F, Giannini EG. Assessing the Short-Term Prognosis of Patients with Cirrhosis Using the DIC Scores. Thromb Haemost. 2023;123(7):744-746. doi:10.1055/a-2039-1575
• Kayali S, Pasta A, Plaz Torres MC, et al. Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis. Liver Int. 2023;43(1):8-17. doi:10.1111/liv.15419
• Cremonini AL, Pasta A, Carbone F, et al. Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic Syndrome. Front Mol Biosci. 2022;9:854624. Published 2022 Jun 8. doi:10.3389/fmolb.2022.854624
• Kayali S, Pasta A, Pellicano R, et al. Effect of contrast-enhanced ultrasound (CEUS) on liver stiffness measurements obtained by transient and shear-wave elastography. Panminerva Med. 2022;64(4):479-484. doi:10.23736/S0031-0808.22.04719-X

Patologie trattate

• malattie gastrointestinali
• Reflusso gastroesofageo (esofagite)
• Esofagite da reflusso
• Epatite
• Epatocarcinoma
• Steatosi epatica non alcolica (NAFLD)
• Steatosi
• Cirrosi epatica
• Dispepsia
• Disfagia
• Dolore addominale
• Colite
• Colite ulcerosa
• Colon irritabile
• Costipazione
• Colestasi
• Calcolosi della colecisti
• Colangite sclerosante
• Malattia di crohn
• Sindrome dell'intestino irritabile
• Ittero
• Intolleranze alimentari
• Celiachia
• helicobacter pylori
• Acalasia Esofagea

Profili social